Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis

Objectives To compare cancer specific survival after thoracoscopic sublobar lung resection and stereotactic ablative radiotherapy (SABR) for tumors ≤2 cm in size and thoracoscopic resection (sublobar resection or lobectomy) and SABR for tumors ≤5 cm in size.

Bibliographic Details
Main Authors: Paul, Subroto, Lee, Paul C, Mao, Jialin, Isaacs, Abby J, Sedrakyan, Art
Format: Online
Language:English
Published: BMJ Publishing Group Ltd. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937638/
id pubmed-4937638
recordtype oai_dc
spelling pubmed-49376382016-07-12 Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis Paul, Subroto Lee, Paul C Mao, Jialin Isaacs, Abby J Sedrakyan, Art Research Objectives To compare cancer specific survival after thoracoscopic sublobar lung resection and stereotactic ablative radiotherapy (SABR) for tumors ≤2 cm in size and thoracoscopic resection (sublobar resection or lobectomy) and SABR for tumors ≤5 cm in size. BMJ Publishing Group Ltd. 2016-07-08 /pmc/articles/PMC4937638/ /pubmed/27400862 http://dx.doi.org/10.1136/bmj.i3570 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Paul, Subroto
Lee, Paul C
Mao, Jialin
Isaacs, Abby J
Sedrakyan, Art
spellingShingle Paul, Subroto
Lee, Paul C
Mao, Jialin
Isaacs, Abby J
Sedrakyan, Art
Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
author_facet Paul, Subroto
Lee, Paul C
Mao, Jialin
Isaacs, Abby J
Sedrakyan, Art
author_sort Paul, Subroto
title Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
title_short Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
title_full Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
title_fullStr Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
title_full_unstemmed Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
title_sort long term survival with stereotactic ablative radiotherapy (sabr) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis
description Objectives To compare cancer specific survival after thoracoscopic sublobar lung resection and stereotactic ablative radiotherapy (SABR) for tumors ≤2 cm in size and thoracoscopic resection (sublobar resection or lobectomy) and SABR for tumors ≤5 cm in size.
publisher BMJ Publishing Group Ltd.
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937638/
_version_ 1613606082625667072